반응 #75823

ord-26a9c631326541d393e542e6e305a58b

반응 조건

상세 조건
See reaction.notes.procedure_details.

후처리

  1. 1
    기타quenched with sat'd ammonium chloride
  2. 2
    추출Extracted with ethyl acetate
  3. 3
    세척washed organics with brine
  4. 4
    건조dried (MgSO4)
  5. 5
    농축concentrated
  6. 6
    기타The residue was purified by prep HPLC (
  7. 7
    세척C18 reverse phase column, elution with a H2O/CH3CN gradient with 0.5% TFA)
  8. 8
    workup.ADDITIONFractions containing desired compound
  9. 9
    추출extracted with ethyl acetate
  10. 10
    건조dried (MgSO4)
  11. 11
    농축concentrated

실험 절차

To a solution of 2-[(7bR,11aS)-1,2,7b,8,9,10,11,11a-octahydro-4H-pyrido[4,3-b][1,4]thiazepino[6,5,4-hi]indol-6-yl]-5-methoxybenzaldehyde, the free base of EXAMPLE 16 (0.03 g, 0.08 mmol), in 5 mL of tetrahydrofuran at 0° C. was added methyl magnesium bromide (0.52 mL of a 3M solution in THF, 1.58 mmol). Stirred with warming to ambient temperature for several hours and then quenched with sat'd ammonium chloride. Extracted with ethyl acetate, washed organics with brine, dried (MgSO4) and concentrated. The residue was purified by prep HPLC (C18 reverse phase column, elution with a H2O/CH3CN gradient with 0.5% TFA). Fractions containing desired compound were then immediately free based with 1 N sodium hydroxide, extracted with ethyl acetate, dried (MgSO4) and concentrated to afford the title compound of EXAMPLE 21. LRMS (ES+): 397.1 (M+H)+.

출처

DOI: 10.6084/m9.figshare.5104873.v1특허: US06699852B2uspto-grants-2004_03